Scotland · NHS Scotland MSAN
H2-antagonists (cimetidine, famotidine and nizatidine)
MSAN(2020)108 · Level 2 · issued 09 Nov 2020
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Medreich Out of stock to be confirmed | Resupply date to be confirmed | — |
| Medreich Out of stock to be confirmed (see table 2 below) | Resupply date to be confirmed | — |
| Medreich Out of stock to be confirmed | Resupply date to be confirmed | — |
| Medreich Out of stock to be confirmed have been sourced | Resupply date to be confirmed | — |
| Medreich Out of stock to be confirmed of nizatidine 150mg | Resupply date to be confirmed | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.